미국의 서방형 코팅 시장 규모, 점유율, 동향 분석 리포트 : 기재별, 용도별, 폴리머 재료별, 부문별 예측(2025-2033년)

U.S. Sustained Release Coatings Market Summary

The U.S. sustained release coatings market size was estimated at USD 169.4 million in 2024 and is projected to reach USD 305.4 million by 2033, growing at a CAGR of 6.2% from 2025 to 2033. The market growth is primarily driven by the rising demand for advanced drug delivery systems that improve therapeutic efficacy and patient adherence, particularly in the treatment of chronic conditions such as diabetes, cardiovascular diseases, and neurological disorders.

The country's robust pharmaceutical R&D ecosystem, supported by significant investments from both innovator and generic drug manufacturers, fosters continuous development of sophisticated coating technologies. The market presents strong growth opportunities driven by the rising adoption of personalized and precision medicine, increasing demand for once-daily or long-acting formulations, and growing use of sustained release technologies in both branded lifecycle management and generics differentiation. Advancements in polymer science, such as the development of biodegradable, plant-based, and smart polymers, are opening new avenues for innovation in drug delivery.

Despite its maturity, the market faces challenges including high formulation development costs, complex regulatory compliance requirements, and the technical difficulty of achieving consistent drug release across diverse patient populations. The need for specialized manufacturing infrastructure and skilled expertise adds to the capital intensity of bringing sustained-release products to the market.

U.S. Sustained Release Coatings Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2033. For this study, Grand View Research has segmented the U.S. sustained release coatings market report based on application, substrate, and polymer material.

• Application Outlook (Volume, Kilotons; Revenue, USD Million, 2021 - 2033)
• In Vitro
• In Vivo
• Substrate Outlook (Volume, Kilotons; Revenue, USD Million, 2021 - 2033)
• Tablets
• Capsules
• Pills
• Polymer Material Outlook (Volume, Kilotons; Revenue, USD Million, 2021 - 2033)
• Ethyl & Methyl Cellulose
• Polyvinyl & Cellulose Acetate
• Methacrylic Acid
• PEG
• Others

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Scope & Assumption
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Substrates & Third-Party Perspectives
  • 1.3.4. Primary Research
• 1.4. Information Analysis
  • 1.4.1. Data Analysis Models
• 1.5. Market Formulation & Data Visualization
• 1.6. List of Data Substrates

Chapter 2. Executive Summary

• 2.1. Market Outlook, 2024 (USD Million) (Kilotons)
• 2.2. Segmental Outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Sustained Release Coatings Market Variables, Trends & Scope

• 3.1. Market Lineage/Ancillary Market Outlook
• 3.2. Industry Value Chain Analysis
  • 3.2.1. Sales Channel Analysis
  • 3.2.2. Manufacturing Trends/Technological Advancements
  • 3.2.3. Raw Material Trends
• 3.3. Price Trend Analysis, 2018 - 2033
  • 3.3.1. Factors Influencing Prices
• 3.4. Regulatory Framework
  • 3.4.1. Analyst Perspective
  • 3.4.2. Regulations & Standards
• 3.5. Market Dynamics
  • 3.5.1. Market Driver Analysis
  • 3.5.2. Market Restraint Analysis
  • 3.5.3. Industry Opportunities
  • 3.5.4. Industry Challenges
• 3.6. Business Environmental Tools Analysis: U.S. Sustained Release Coatings Market
  • 3.6.1. Porter's Five Forces Analysis
    • 3.6.1.1. Bargaining Power of Suppliers
    • 3.6.1.2. Bargaining Power of Buyers
    • 3.6.1.3. Threat of Substitution
    • 3.6.1.4. Threat of New Entrants
    • 3.6.1.5. Competitive Rivalry
  • 3.6.2. PESTLE Analysis
    • 3.6.2.1. Political Landscape
    • 3.6.2.2. Economic Landscape
    • 3.6.2.3. Social Landscape
    • 3.6.2.4. Polymer Material Landscape
    • 3.6.2.5. Environmental Landscape
    • 3.6.2.6. Legal Landscape

Chapter 4. U.S. Sustained Release Coatings Market: Application Estimates & Trend Analysis

• 4.1. Key Takeaways
• 4.2. Application Movement Analysis & Market Share, 2024 & 2033
  • 4.2.1. U.S. Sustained Release Coatings Market By Application, 2021 - 2033 (USD Million) (Kilotons)
• 4.3. In Vitro
  • 4.3.1. U.S. Sustained Release Coatings Market Estimates And Forecasts, for In Vitro, 2021 - 2033 (USD Million) (Kilotons)
• 4.4. In Vivo
  • 4.4.1. U.S. Sustained Release Coatings Market Estimates And Forecasts, for In Vivo, 2021 - 2033 (USD Million) (Kilotons)

Chapter 5. U.S. Sustained Release Coatings Market: Substrate Estimates & Trend Analysis

• 5.1. Key Takeaways
• 5.2. Substrate Movement Analysis & Market Share, 2024 & 2033
• 5.3. U.S. Sustained Release Coatings Market By Substrate, 2021 - 2033 (USD Million) (Kilotons)
• 5.4. Tablets
  • 5.4.1. U.S. Sustained Release Coatings Market Estimates And Forecasts, for Tablets, 2021 - 2033 (USD Million)
• 5.5. Capsules
  • 5.5.1. U.S. Sustained Release Coatings Market Estimates And Forecasts, for Capsules, 2021 - 2033 (USD Million)
• 5.6. Pills
  • 5.6.1. U.S. Sustained Release Coatings Market Estimates And Forecasts, for Pills, 2021 - 2033 (USD Million)

Chapter 6. U.S. Sustained Release Coatings Market: Polymer Material Estimates & Trend Analysis

• 6.1. Key Takeaways
• 6.2. Polymer Material Movement Analysis & Market Share, 2024 & 2033
• 6.3. U.S. Sustained Release Coatings Market By Polymer Material, 2021 - 2033 (USD Million) (Kilotons)
• 6.4. Ethyl & Methyl Cellulose
  • 6.4.1. U.S. Sustained Release Coatings Market Estimates And Forecasts, for Ethyl & Methyl Cellulose, 2021-203 (USD Million)
• 6.5. Polyvinyl & Cellulose Acetate
  • 6.5.1. U.S. Sustained Release Coatings Market Estimates And Forecasts, for Polyvinyl & Cellulose Acetate, 2021 - 2033 (USD Million)
• 6.6. Methacrylic Acid
  • 6.6.1. U.S. Sustained Release Coatings Market Estimates And Forecasts, for Hot melt, 2021 - 2033 (USD Million)
• 6.7. PEG
  • 6.7.1. U.S. Sustained Release Coatings Market Estimates And Forecasts, for PEG, 2021 - 2033 (USD Million)
• 6.8. Others
  • 6.8.1. U.S. Sustained Release Coatings Market Estimates And Forecasts, for Others, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Key Players, their Recent Developments, and their Impact on Industry
• 7.2. Competition Categorization
• 7.3. Company Market Position Analysis
• 7.4. Company Heat Map Analysis
• 7.5. Strategy Mapping, 2024
• 7.6. Company Listing
  • 7.6.1. BASF SE
    • 7.6.1.1. Company Overview
    • 7.6.1.2. Financial Performance
    • 7.6.1.3. Product Type Benchmarking
    • 7.6.1.4. Strategic Initiatives
  • 7.6.2. Evonik
    • 7.6.2.1. Company Overview
    • 7.6.2.2. Financial Performance
    • 7.6.2.3. Product Type Benchmarking
    • 7.6.2.4. Strategic Initiatives
  • 7.6.3. Colorcon
    • 7.6.3.1. Company Overview
    • 7.6.3.2. Financial Performance
    • 7.6.3.3. Product Type Benchmarking
    • 7.6.3.4. Strategic Initiatives
  • 7.6.4. Coating Place, Inc.
    • 7.6.4.1. Company Overview
    • 7.6.4.2. Financial Performance
    • 7.6.4.3. Product Type Benchmarking
    • 7.6.4.4. Strategic Initiatives
  • 7.6.5. Teva Pharmaceutical Industries Ltd.
    • 7.6.5.1. Company Overview
    • 7.6.5.2. Financial Performance
    • 7.6.5.3. Product Type Benchmarking
    • 7.6.5.4. Strategic Initiatives
  • 7.6.6. Pfizer, Inc.
    • 7.6.6.1. Company Overview
    • 7.6.6.2. Financial Performance
    • 7.6.6.3. Product Type Benchmarking
    • 7.6.6.4. Strategic Initiatives
  • 7.6.7. Sun Pharmaceutical Industries Ltd.
    • 7.6.7.1. Company Overview
    • 7.6.7.2. Financial Performance
    • 7.6.7.3. Product Type Benchmarking
    • 7.6.7.4. Strategic Initiatives
  • 7.6.8. Novartis AG
    • 7.6.8.1. Company Overview
    • 7.6.8.2. Financial Performance
    • 7.6.8.3. Product Type Benchmarking
    • 7.6.8.4. Strategic Initiatives
  • 7.6.9. AstraZeneca
    • 7.6.9.1. Company Overview
    • 7.6.9.2. Financial Performance
    • 7.6.9.3. Product Type Benchmarking
    • 7.6.9.4. Strategic Initiatives
  • 7.6.10. GlaxoSmithKline plc
    • 7.6.10.1. Company Overview
    • 7.6.10.2. Financial Performance
    • 7.6.10.3. Product Type Benchmarking
    • 7.6.10.4. Strategic Initiatives
  • 7.6.11. AbbVie Inc.
    • 7.6.11.1. Company Overview
    • 7.6.11.2. Financial Performance
    • 7.6.11.3. Product Type Benchmarking
    • 7.6.11.4. Strategic Initiatives